Compared with subjects in the control group , those in the intensive group had decreased levels of total cholesterol ( 3.99 1.08 vs 3.76 0.98 ; P < .05 ) , systolic blood pressure ( 142.41 11.53 vs 135.71 14.57 mm Hg ; P < .05 ) , low-density lipoprotein cholesterol ( LDL-C ) ( 2.72 1.01 vs 2.42 0.81 ; P < .05 ) , and body mass index ( 25.13 5.12 vs 24.23 6.22 ; P < .05 ) ; a higher percentage with target LDL-C < 2.6 mmol/L ( 66.99 % vs 47.88 % ; P < .05 ) ; increased use of medication including aspirin ( 96.51 % vs 99.26 % ; P < .05 ) , clopidogrel ( 87.53 % vs 98.77 % ; P < .05 ) , statins ( 52.62 % vs 93.10 % ; P < .05 ) , - blockers ( 48.63 % vs 61.33 % ; P < .05 ) , and angiotensin-converting enzyme inhibitors ( 32.92 % vs 61.82 % ; P < .05 ) ; and better dietary control and physical exercise ( 55.66 % vs 26.18 % , P < .05 ; 62.56 % vs 38.65 % , P < .05 ) .